WAILEA, Hawaii — “For those of you in retina or have retina in your practice I am sure this is a topic of conversation – the government is coming after anti-VEGF therapy from all directions,” said an expert in healthcare law.
“They are coming from the OIG. The Office of the Inspector General is auditing individual physicians right now looking at their use of anti-VEGF therapy and services provided on the same day,” Allison W. Shuren, JD, MSN, who is a partner at Arnold & Porter and co-chairs the Life Sciences and Healthcare Regulatory practice said. “The